Ferramentas de busca na internet para educação médica: vantagens e desvantagens do Google Acadêmico, Pubmed e Scielo

Os principais sítios eletrônicos gratuitos para busca de artigos científicos em Medicina são o PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) e o Google Acadêmico – GA (http://scholar.google.com.br/). O Scielo (http://www.scielo.org) também é importante para a busca de artigos latino-americanos. É assumido pela comunidade médica que o PubMed é a melhor ferramenta de busca, entretanto, algumas temáticas como a educação médica podem não ser totalmente contempladas no PubMed. O objetivo é verificar se o GA pode ser uma ferramenta útil para busca de artigos científicos referenciados na temática em educação médica, com foco no currículo médico e ética, comparados ao Pubmed e ao Scielo. É um estudo transversal, com análise qualiquantitativa sobre artigos científicos completos publicados no GA, PubMed e Scielo, no período entre 01/01/2011 a 31/12/2011, levantados entre 01 a 30/06/2012. Utilizaram-se as palavras-chaves em inglês: “medical curriculum” and “ethics”. O GA obteve 321 artigos completos de acesso livre; o PubMed resgatou três e o Scielo obteve-se apenas um resultado. A diferença entre o GA e o Pubmed talvez possa ser explicada pelo tipo de revistas indexadas no Pubmed,com maior foco em ciências básicas em biologia e saúde. O baixo retorno de artigos oriundos da busca no Scielo pode ser decorrente da própria ferramenta de busca, feita apenas pelos termos indexados como palavras-chaves. A análise preliminar quantitativa aponta que o GA pode ser útil na busca de artigos em educação médica, mas a análise qualitativa dos artigos deverá ainda ser realizada e outros termos em educação médica ainda serão pesquisados

Minor-but-Complex Liver Resection: An Alternative to Major Resections for Colorectal Liver Metastases Involving the Hepato-Caval Confluence

Major hepatectomy (MH) is often considered the only possible approach for colorectal liver metastasis (CRLM) at the hepato-caval confluence (CC), but it is associated with high morbidity and mortality. With the aim to reduce MH, we developed the "minor-but-complex" (MbC) technique, which consists in the resection of less than 3 adjacent liver segments with exposure of the CC and preservation of hepatic outflow until spontaneous maturation of peripheral intrahepatic shunts between main hepatic veins. We have evaluated applicability and outcome of MbC resections for the treatment of CRLM involving the CC. In this retrospective cohort study, all consecutive liver resections (LR) performed for CRLM located in segments 1, 7, 8, or 4a were classified as MINOR - removal of bC - removal of = 3 adjacent segments. The rate of avoided MH was obtained by the difference between the rate of potentially MH (PMH) plus potentially inoperable cases and the rate of the MH performed. Taking into account that postoperative mortality is mainly related to the amount of resected liver, MbC was compared with minor resections for safety, complexity, and outcome. Of the 59 LR analyzed, 29 (49.1%) were deemed PMH and 4 (6.8%) potentially inoperable. Eventually, MH was performed only in 8 (13.5%) with a decrease rate of 42.4%. Minor LR was performed in 23 (39.0%) and MbC LR in 28 (47.5%) patients. Among MbC cases, 32.1% had previous liver treatments, 39.3% required vascular reconstruction (no reconstructed vessel thrombosis occurred before maturation of peripheral intrahepatic shunts between main hepatic veins), and 7.1% had grade IIIb-IV complications, their median hospital stay was 9 days and 90-day mortality was 0%. After a median follow-up of 22.2 months, oncological results were comparable with those of minor resections. MbC hepatectomy lowers the need for MH and allows for the resection of potentially inoperable patients without negative impact on safety and survival

Video-assisted parathyroidectomy: a series of 85 cases

Abstract AIM OF THE STUDY: To verify the feasibility of video-assisted parathyroidectomy, set up the indications and report the results in a series of 85 patients. MATERIAL AND METHODS: From 1997 to 1999, 85 patients affected by primary hyperparathyroidism due to single gland disease, with an adenoma smaller than 35 mm as demonstrated by preoperative imaging, were referred for video-assisted parathyroidectomy. There were 62 females and 23 males. Mean age was 53 years, (range 23-82). Video-assisted parathyroidectomy was associated with intra-operative PTH quick-assay. Calcium testing was controlled before leaving the hospital, 1 month and 3 months later, and postoperative laryngoscopy was performed in all patients. RESULTS: There were five conversions to open cervicotomy: three due to a contra-lateral second adenoma, two because of an intrathyroidal adenoma. The mean operative time for video-assisted procedure was 59 minutes (range: 25-180). Circulating PTH levels 10 minutes after the removal of the affected gland(s) always dropped significantly, and pathological report confirmed the parathyroid nature of the specimens (mean diameter 13 mm, range 7-35). Morbidity consisted of five cases of transient hypocalcemia and one permanent laryngeal nerve paralysis. We registered no persistent or recurrent disease (mean follow-up 12.8 months, range 1-28). CONCLUSIONS: Video-assisted parathyroidectomy is feasible, and its results are similar to those of traditional procedure, while it seems superior as regards postoperative course and aesthetic results. It also allows different strategical decisions even during operation (i.e. bilateral exploration or thyroid lobectomy) by the same approach

Desigualdades sociais e uso de serviços de saúde: evidências de análise estratificada

OBJECTIVE: The study aims to identify children who are not benefited by local health programs, looking for to characterize the excluded segment of the population in order to broaden the access to and use of the main actions provided by local health programs. METHODS: A sample of 465 children aged less than 1 year was studied, living in the year of 1996 in Embu, a city of the metropolitan area of S. Paulo, Brazil. Our hypothesis was that there is a higher availability of private health care resources among families who haven't been using the local health program. The statistical analysis consisted of stratified association analysis to study the heterogeneity between and intra four strata of families defined by different socialeconomic conditions. RESULTS: Although only 85.4% of the study children were enrolled in local health services, 91.2% of them were being benefited by main health care actions. The analysis of differences intra strata revealed that our hypothesis was only corroborated in one stratum. It is in the stratum 3, which concentrates the peripheral population, where we could find children who have not been using the local health program in Embu city. CONCLUSIONS: In the same social segment it was detected some inner heterogeneity among families related to the availability of private resources for their children health care.OBJETIVO: Identificar os grupos populacionais não alcançados pelo programa local de saúde materno-infantil, buscando caracterizar os possíveis pontos de exclusão, com vistas ao estudo de intervenções capazes de ampliar o acesso e a utilização das principais ações de saúde oferecidas pelo programa. MÉTODOS: Estudou-se uma amostra de 465 menores de um ano residentes no Município de Embu, SP (Brasil). A análise estatística, orientada pela hipótese que esperava maior disponibilidade de planos de saúde entre as famílias que não usavam o programa local de saúde infantil, consistiu em análises de associação estratificadas que buscaram detectar heterogeneidade entre os quatro estratos de famílias e no interior deles, definidos segundo diferentes padrões de condições de vida. RESULTADOS: Apesar de apenas 85,4% das crianças estudadas serem matriculadas nas unidades básicas de saúde, 91,2 % eram assistidas pelas principais ações de saúde. No estrato 3, onde reside a população periférica, estão concentradas as crianças não alcançadas pelo programa. O estudo de diferenças dentro dos estratos revelou que também no estrato 3 encontra-se a possibilidade de que algumas famílias estejam usando convênios ou planos de saúde como alternativa ao programa local de saúde. Os resultados apontam ainda que a população com piores condições de vida (favelas) dispõe do sistema público do município como única alternativa para cuidar de sua saúde. CONCLUSÕES: É na população residente na periferia do município que se concentram as crianças não assistidas pelo programa local de saúde infantil e existe maior heterogeneidade entre as famílias quanto à disponibilidade de outros recursos para os cuidados de saúde de suas crianças

Performance Of A Liquid Argon Time Projection Chamber Exposed To The WANF Neutrino Beam

We present the results of the first exposure of a Liquid Argon TPC to a multi-GeV neutrino beam. The data have been collected with a 50 liters ICARUS-like chamber located between the CHORUS and NOMAD experiments at the CERN West Area Neutrino Facility (WANF). We discuss both the instrumental performance of the detector and its capability to identify and reconstruct low multiplicity neutrino interactions.Comment: 14 pages, 12 figures. Submitted for publication to Physical Review

An unexpected role for caspase-2 in neuroblastoma

Caspase-2 has been implicated in various cellular functions, including cell death by apoptosis, oxidative stress response, maintenance of genomic stability and tumor suppression. The loss of the caspase-2 gene (Casp2) enhances oncogene-mediated tumorigenesis induced by E1A/Ras in athymic nude mice, and also in the Eμ-Myc lymphoma and MMTV/c-neu mammary tumor mouse models. To further investigate the function of caspase-2 in oncogene-mediated tumorigenesis, we extended our studies in the TH-MYCN transgenic mouse model of neuroblastoma. Surprisingly, we found that loss of caspase-2 delayed tumorigenesis in the TH-MYCN neuroblastoma model. In addition, tumors from TH-MYCN/Casp2(-/-) mice were predominantly thoracic paraspinal tumors and were less vascularized compared with tumors from their TH-MYCN/Casp2(+/+) counterparts. We did not detect any differences in the expression of neuroblastoma-associated genes in TH-MYCN/Casp2(-/-) tumors, or in the activation of Ras/MAPK signaling pathway that is involved in neuroblastoma progression. Analysis of expression array data from human neuroblastoma samples showed a correlation between low caspase-2 levels and increased survival. However, caspase-2 levels correlated with clinical outcome only in the subset of MYCN-non-amplified human neuroblastoma. These observations indicate that caspase-2 is not a suppressor in MYCN-induced neuroblastoma and suggest a tissue and context-specific role for caspase-2 in tumorigenesis.L Dorstyn, J Puccini, A Nikolic, S Shalini, CH Wilson, MD Norris, M Haber and S Kuma

Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy.

After FDA and EMA approval of the regimen containing polatuzumab vedotin plus rituximab and bendamustine (PolaBR), eligible relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients in Italy were granted early access through a Named Patient Program. A multicentric observational retrospective study was conducted focusing on the effectiveness and safety of PolaBR in everyday clinical practice. Fifty-five patients were enrolled. There were 26 females (47.3%), 32 patients were primary refractory and 45 (81.8%) resulted refractory to their last therapy. The decision to add or not bendamustine was at physician's discretion. Thirty-six patients underwent PolaBR, and 19 PolaR. The 2 groups did not differ in most of baseline characteristics. The final overall response rate was 32.7% (18.2% complete response rate), with a best response rate of 49.1%. Median disease-free survival was reached at 12 months, median progression-free survival at 4.9 months and median overall survival at 9 months, respectively. Overall, 88 adverse events (AEs) were registered during treatment in 31 patients, 22 of grade ≥3. Eight cases of neuropathy occurred, all of grades 1-2 and all related to polatuzumab. The two groups of treatment did not differ for effectiveness endpoints but presented statistically significant difference in AEs occurrence, especially in hematological AEs, in AEs of grade equal or greater than 3 and in incidence of neuropathy. Our data add useful information on the effectiveness of Pola(B)R in the setting of heavily pretreated DLBCL and may also suggest a better tolerability in absence of bendamustine without compromise of efficacy